Fatty acids with greater than 22 carbon atoms (very long chain fatty a
cids, VLCFA) are present in small amounts in most animal tissues. Satu
rated and monoenoic VLCFA are major components of brain, while the pol
yenoic VLCFA occur in significant amounts in certain specialized anima
l tissues such at retina and spermatozoa. Biosynthesis of VLCFA occurs
by carbon chain elongation of shorter chain fatty acid precursors whi
le beta-oxidation takes place almost exclusively in peroxisomes. Mitoc
hondria are unable to oxidize VLCFA because they lack a specific VLCFA
coenzyme A synthetase, the first enzyme in the beta-oxidation pathway
. VLCFA accumulate in the tissues of patients with inherited abnormali
ties in peroxisomal assembly, and also in individuals with defects in
enzymes catalyzing individual reactions along the beta-oxidation pathw
ay. It is believed that the accumulation of VLCFA in patient tissues c
ontributes to the severe pathological changes which are a feature of t
hese conditions. However, little is known of the role of VLCFA in norm
al cellular processes, and of the molecular basis for their contributi
on to the disease process. The present review provides an outline of t
he current knowledge of VLCFA including their biosynthesis, degradatio
n, possible function and involvement in human disease.